Research at University Health Network
 
Technology Transfer
Menu Level 3  
   
 
Dr. Michael Reedijk, MD, PhD, MD, PhD
Affiliate Scientist, Princess Margaret Cancer Centre
Research Interests
Notch Signaling in breast cancer

The Notch signaling cascade is highly conserved and plays a crucial role in stem cell self-renewal, cell fate determination, epithelial cell polarity/adhesion, cell division and apoptosis in organisms from nematodes to vertebrates. Elevated expression of the Notch ligand JAG1, Notch pathway activation and expression of Notch target genes are defining features of poor-prognosis breast cancer. Currents efforts in the laboratory are directed towards elucidating the mechanism(s) by which activated Notch signaling contributes to breast cancer development. We are using genome-wide approaches including expression array analyses, chromatin immunoprecipitation and a large-scale RNA interference- and chemical compound-based screens to identify novel regulators and targets of Notch activation in breast cancer. The value of identifying Notch regulators and targets is for their ultimate exploitation as biomarkers or therapeutic targets in Notch-activated cancers.

Pubmed Publications
Perform an automatic PubMed search of this researcher's publications.
 
 
 
  Dr. Michael Reedijk, MD, PhD
Mailing Address
Primary LAB
Princess Margaret Cancer Centre
8th 8-111
610 University Avenue
Toronto, Ontario
Canada M5G 2M9

Primary LAB
Princess Margaret Cancer Centre
610 University Avenue
Toronto, Ontario
Canada M5G 2M9

 
Email

Phone Numbers
416-946-4432(Primary)
416-946-4501 x 3590(LAB)

 

   
 
 
 
Home Researchers Facilities Support Services Programs Commercialization Ethics News About UHN Institutes OCI Techna TGRI TRI TWRI